Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with an acute stroke caused by reduced blood flow to the brain, or a sudden loss of blood supply to the eye, within the last two weeks
- People whose stroke or eye event appears to be linked to a specific type of fatty deposit (plaque) in the carotid artery on the same side as the affected area, where the plaque is causing a 10–49% narrowing of the artery
- People where no other clear cause for the stroke has been found (such as a heart or large blood vessel source), based on standard heart and blood vessel tests
- People whose carotid artery plaque shows high-risk features on a CT scan or MRI — specifically, at least two of the following: plaque thickness of 3mm or more, irregular plaque surface, ulceration, less than 50% calcification, or a fatty core; OR at least one of the following: bleeding within the plaque
- People whose carotid artery shows a specific shelf-like or smooth ridge-like abnormality known as a carotid web
- People whose plaque imaging results have been reviewed and confirmed by an independent review centre
- People aged 18 or older
- People whose level of physical disability at the time of joining the trial is mild to moderate (confirm with trial site)
- People who are already receiving dual antiplatelet therapy (two types of blood-thinning medication) as part of their standard care before any procedure
Who may not be able to join:
- People who have a complete blockage of the carotid artery requiring emergency treatment
- People whose stroke involved blood vessel territories other than the carotid artery on the affected side
- People whose stroke is likely to have been caused by small vessel disease, major artery narrowing of 50% or more, a clot from the heart, or another known condition such as blood vessel inflammation
- People whose plaque is made up of 50% or more calcium deposits, as seen on CT scan
- People who have a blood clot sitting inside the carotid artery
- People whose blood vessels are very curved or twisted (more than 90 degrees), which may make safe placement of a stent difficult
- People who have previously had a carotid surgery or stent procedure and have developed narrowing again at the same site
- People with blood clotting disorders
- People for whom reaching the affected area of the carotid artery is not possible, or carries a higher than acceptable risk
- People whose plaque is located at the very beginning (opening) of the main carotid artery
- People with a known allergy to nickel-titanium (the material used in the stent)
- People with a known allergy to heparin (a blood-thinning medication)
- People with any condition that reduces life expectancy to less than 12 months
- People with any condition that increases the risk of endovascular (stent-based) procedures
- People who would not be able to attend follow-up clinic visits each year
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +49 (0) 7231 - 155 00 171
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary Endpoint as rate of events of ipsilateral recurrent ischemic stroke or ipsilateral retinal artery ischemia analysed as time to first occurence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.